People with advanced lung cancer experience higher levels of symptom burden and psychological distress than other groups of cancer and the general population. In particular, patients with advanced lun
Eribulin, irinotecan, and the combination were studied in ES4 xenograft model. RNAs from xenograft tumors were harvested at 24h and 144h after single agent or combination treatment to analyze gene exp
These data provide scientific information to understand the mechanism of action of lapatinib resistance in HER2-positive patients and to test the combination of HER2-targeted agents and GSK1363089 (fo
Combination index (CI) values for combined treatment of DPP4 inhibitors and doxorubicin in CRC cell lines. CI 1 indicate synergistic, additive, and antagonistic effects, respectively. µM: micromolar.